Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jul-Aug;23(4):263-264.
doi: 10.4103/sjg.SJG_136_17.

Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients

Said A Al-Busafi  1 , Heba Omar  2
Affiliations
Comment

Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients

Said A Al-Busafi et al. Saudi J Gastroenterol. 2017 Jul-Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Comment on

References

    1. Alghamdi AS, Alqutub A, Abaalkhail F, Sanai FM, Alghamdi H, Altraif I, et al. SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection. Saudi J Gastroenterol. 2015;21:60–3. - PMC - PubMed
    1. Alghamdi AS, Alghamdi M, Sanai FM, Alghamdi H, Aba-Alkhail F, Alswat K, et al. SASLT Guidelines: Update in Treatment of Hepatitis C Virus Infection. Saudi J Gastroenterol. 2016;22(Suppl 2):S25–S57. - PMC - PubMed
    1. Freeman JA, Hill A. The use of generic medications for hepatitis C. Liver Int. 2016;36:929–32. - PMC - PubMed
    1. Edwards DJ, Coppens DG, Prasad TL, Rook LA, Iyer JK. Access to hepatitis C medicine. Bull World Health Organ. 2015;93:799–805. - PMC - PubMed
    1. Freeman J, Sallie R, Kennedy A, Hieu PT, Jeffreys G, Hill AM. High sustained virological response rates using generic Direct Acting Antiviral treatment for Hepatitis C, imported into Australia. J Hepatol. 2016;2:S209.

Substances